Fig. 1 · Structure
Documents & Downloads
Rilmazolam
Rilmazafone Metabolite
Rilmazolam is a triazolobenzodiazepine that serves as an active metabolite of Rilmazafone. This compound exhibits significant anxiolytic and sedative properties, making it valuable for research into sleep disorders and anxiety-related conditions. Its pharmacological profile facilitates investigations into the mechanisms of action of benzodiazepines and their therapeutic applications in neuropharmacology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 50330-59-1 |
| Applications | Rilmazafone Metabolite |
| Formula | C19H15Cl2N5O |
| Molecular Weight | 400.26 |
| SMILES | O=C(N(C)C)C1=NN(C2=C(C(C3=C(Cl)C=CC=C3)=NC4)C=C(Cl)C=C2)C4=N1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.